Combined Nabpaclitaxel Pressurized IntraPeritoneal Aerosol Chemotherapy With Systemic Nabpaclitaxel-Gemcitabine Chemotherapy for Pancreatic Cancer Peritoneal Metastases
Clinical trial NCT05371223 · UNKNOWN
Trial details
- NCT number
- NCT05371223
- Sponsor
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-01
- Primary completion
- 2025-05-30
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.